Wird geladen...
EZH2 inhibitor GSK343 inhibits sepsis-induced intestinal disorders
Enhancer of zeste homolog 2 (EZH2) is positively associated with poor clinical outcomes in a number of aggressive tumors. Recent studies have demonstrated that inhibition of EZH2 also suppressed the inflammatory response during sepsis. The present study aimed to investigate whether an inhibitor of E...
Gespeichert in:
| Veröffentlicht in: | Exp Ther Med |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
D.A. Spandidos
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7967880/ https://ncbi.nlm.nih.gov/pubmed/33747174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2021.9854 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|